Neurobiology of obsessive-compulsive disorder

被引:15
作者
Karch, S. [1 ]
Pogarell, O. [1 ]
机构
[1] Univ Munich, Klin Psychiat & Psychotherapie, D-80336 Munich, Germany
来源
NERVENARZT | 2011年 / 82卷 / 03期
关键词
Obsessive-compulsive disorder; Neurobiology; Treatment strategies; Frontostriatal networks; Orbitofrontal-striatal model; CEREBRAL-BLOOD-FLOW; GLUCOSE-METABOLISM; THERAPY; BEHAVIORS; CHECKING; DOPAMINE;
D O I
10.1007/s00115-010-2964-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the last few decades, neurobiological research has considerably improved the understanding of the pathophysiological basis of obsessive-compulsive disorder (OCD), indirectly contributing to the improvement of diverse therapy strategies. A number of functional imaging studies have indicated functional deficits in frontostriatal networks, which can be subsumed in an orbitofrontal model of obsessive-compulsive disorder. A dysfunction is postulated in parallel frontostriatal circuits, leading to an imbalance in direct and indirect feedback loops and a disinhibition of thalamocortical activity. Neurochemical studies have shown that OCD is linked to changes of the central modulatory transmitter system, especially, the serotonin and dopamine system, which probably contribute to a direct and indirect dysregulation in various neural networks. Pharmacologically, the elucidation of these serotonergic and dopaminergic alterations and their interactions are of special interest.
引用
收藏
页码:299 / +
页数:7
相关论文
共 33 条
[1]   Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei [J].
Adams, KH ;
Hansen, ES ;
Pinborg, LH ;
Hasselbalch, SG ;
Svarer, C ;
Holm, S ;
Bolwig, TG ;
Knudsen, GM .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, 8 (03) :391-401
[2]   FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder [J].
Brody, AL ;
Saxena, S ;
Schwartz, JM ;
Stoessel, PW ;
Maidment, K ;
Phelps, ME ;
Baxter, LR .
PSYCHIATRY RESEARCH-NEUROIMAGING, 1998, 84 (01) :1-6
[3]   Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives [J].
Chamberlain, Samuel R. ;
Menzies, Lara ;
Hampshire, Adam ;
Suckling, John ;
Fineberg, Naomi A. ;
del Campo, Natalia ;
Aitken, Mike ;
Craig, Kevin ;
Owen, Adrian M. ;
Bullmore, Edward T. ;
Robbins, Trevor W. ;
Sahakian, Barbara J. .
SCIENCE, 2008, 321 (5887) :421-422
[4]  
Denys D, 2004, J CLIN PSYCHIAT, V65, P11
[5]   Neuroimaging studies of obsessive-compulsive disorder in adults and children [J].
Friedlander, L ;
Desrocher, M .
CLINICAL PSYCHOLOGY REVIEW, 2006, 26 (01) :32-49
[6]  
Hegerl U, 2002, PSYCHOTHERAPIE, V7, P228
[7]   Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders [J].
Hoehn-Saric, R ;
Schlaepfer, TE ;
Greenberg, RD ;
McLeod, DR ;
Pearlson, GD ;
Wong, SH .
PSYCHIATRY RESEARCH-NEUROIMAGING, 2001, 108 (02) :89-100
[8]  
HOLLANDER E, 1995, J NEUROPSYCH CLIN N, V7, P485
[9]   Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors [J].
Kim, C. H. ;
Cheon, K. A. ;
Koo, M. -S. ;
Ryu, Y. H. ;
Lee, J. D. ;
Chang, J. W. ;
Lee, H. S. .
NEUROPSYCHOBIOLOGY, 2007, 55 (3-4) :156-162
[10]   Neuroimaging in obsessive-compulsive disorder [J].
Kwon, Jun Soo ;
Jang, Joon Hwan ;
Choi, Jung-Seok ;
Kang, Do-Hyung .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (02) :255-269